Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders

23Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Atrial septal defect (ASD) and patent foramen ovale (PFO) are common clinical congenital heart defects. As an effective method for the treatment of ASD and PFO, transcatheter closure with occluders presents many advantages, including safety, ease of operation, minimal invasiveness, and reduced complications. This contribution reviews the various types of occluders currently used in clinical applications and under development, including non degradable occluders, partially degradable occluders, and totally degradable occluders. A number of case studies are described in detail. Comparison is made on the treatment outcomes using different occulders. Future development of transcatheter closure is discussed, in particular the use of totally degradable occluders. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 433–443, 2018.

Cite

CITATION STYLE

APA

Tang, B., Su, F., Sun, X., Wu, Q., Xing, Q., & Li, S. (2018, January 1). Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders. Journal of Biomedical Materials Research - Part B Applied Biomaterials. John Wiley and Sons Inc. https://doi.org/10.1002/jbm.b.33831

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free